Emerald Mutual Fund Advisers Trust Ironwood Pharmaceuticals Inc Transaction History
Emerald Mutual Fund Advisers Trust
- $1.77 Billion
- Q3 2024
A detailed history of Emerald Mutual Fund Advisers Trust transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 197,396 shares of IRWD stock, worth $696,807. This represents 0.05% of its overall portfolio holdings.
Number of Shares
197,396
Previous 644,153
69.36%
Holding current value
$696,807
Previous $4.2 Million
80.69%
% of portfolio
0.05%
Previous 0.24%
Shares
2 transactions
Others Institutions Holding IRWD
# of Institutions
238Shares Held
162MCall Options Held
11.2MPut Options Held
9.1K-
Black Rock Inc. New York, NY22.9MShares$80.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA22MShares$77.8 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$57.9 Million16.75% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.3MShares$39.8 Million0.11% of portfolio
-
State Street Corp Boston, MA9.92MShares$35 Million0.0% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $541M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...